HomeInsightsStock Comparison

Alkem Laboratories Ltd vs Sun Pharma Advanced Research Company Ltd Stock Comparison

Alkem Laboratories Ltd vs Sun Pharma Advanced Research Company Ltd Stock Comparison

Last Updated on: May 24, 2025

Key Highlights

  • The Latest Trading Price of Alkem Laboratories Ltd is ₹ 5285 as of 23 May 15:30.
  • The P/E Ratio of Alkem Laboratories Ltd changed from 24.7 on March 2020 to 32.9 on March 2024 . This represents a CAGR of 5.90% over 5 yearsThe P/E Ratio of Sun Pharma Advanced Research Company Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Alkem Laboratories Ltd changed from ₹ 27844 crore on March 2020 to ₹ 59067 crore on March 2024 . This represents a CAGR of 16.23% over 5 yearsThe Market Cap of Sun Pharma Advanced Research Company Ltd changed from ₹ 5823 crore on March 2023 to ₹ 12005 crore on March 2024 . This represents a CAGR of 43.58% over 2 years.
  • The revenue of Alkem Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 3467 crore. This represent the decline of -100% The revenue of Sun Pharma Advanced Research Company Ltd for the Mar '25 is ₹ 27.19 crore as compare to the Dec '24 revenue of ₹ 15.1 crore. This represent the growth of 80.07%.
  • The ebitda of Alkem Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 852.38 crore. This represent the decline of -100% The ebitda of Sun Pharma Advanced Research Company Ltd for the Mar '25 is ₹ -53.18 crore as compare to the Dec '24 ebitda of ₹ -73.5 crore. This represent the decline of -27.65%.
  • The net profit of Alkem Laboratories Ltd changed from ₹ 287.81 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Sun Pharma Advanced Research Company Ltd changed from ₹ -95.35 crore to ₹ -59.77 crore over 8 quarters. This represents a CAGR of -20.83% .
  • The Dividend Payout of Alkem Laboratories Ltd changed from 23.64 % on March 2020 to 27.37 % on March 2024 . This represents a CAGR of 2.97% over 5 yearsThe Dividend Payout of Sun Pharma Advanced Research Company Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alkem Laboratories Ltd

  • Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations.
  • The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
  • The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets.
  • With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales.
  • The company also has presence in more than 40 international markets, with the United States being its key focus market. Alkem Laboratories Limited was incorporated as a private limited company on August 8, 1973 in Patna and subsequently became a deemed public limited company on October 26, 1988.

About Sun Pharma Advanced Research Company Ltd

  • Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
  • The Company works on innovation and new product development for global markets.
  • They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Ltd was incorporated on March 1, 2006 as an innovative and development company.
  • They commenced operations on March 22, 2006.
  • As per Scheme of Arrangement, all assets and liabilities of the Innovative Research & Development business including Novel Drug Delivery System (NDDS) division of Sun Pharmaceuticals Industries' Research & Development undertaking stands transferred and vested in the Company with effect from Appointed date on February 28, 2007.

Alkem Laboratories Ltd News Hub

News

Alkem Laboratories to discuss results

Alkem Laboratories will hold a meeting of the Board of Directors of the Company on 29 May ...

Read more

17 May 2025 15:23

News

Alkem MedTech acquires Bombay Ortho Industries

Alkem Laboratories announced that its wholly owned subsidiary, Alkem MedTech has completed...

Read more

17 Apr 2025 09:43

News

Alkem Labs' subsidiary concludes acquisition of 100% stake in Bombay Ortho

In February this year, Alkem Medtech had executed a binding offer outlining the terms and ...

Read more

17 Apr 2025 14:49

News

Alkem Lab gains as Bioequivalence Center clears USFDA inspection without observations

The inspection, conducted from March 10 to March 13, 2025, concluded that no Form 483 had ...

Read more

17 Mar 2025 09:57

News

Alkem Lab's Bioequivalence Center clears USFDA inspection without observations

The inspection concluded that no Form 483 had been issued. Alkem Laboratories is engaged i...

Read more

15 Mar 2025 12:44

News

Alkem Laboratories launches generic empagliflozin in India

Alkem Laboratories announced the launch of generic empagliflozin and its combinations in I...

Read more

12 Mar 2025 10:26

Sun Pharma Advanced Research Company Ltd News Hub

News

Sun Pharma Advanced Research Company to table results

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

13 May 2025 15:59

News

Sun Pharma Advanced Research Company submits IND application to USFDA

Sun Pharma Advanced Research Company announced submission of an Investigational New Drug (...

Read more

31 Mar 2025 10:19

News

SPARC submits application for its ADC to US FDA to conduct global phase-1 study

The IND application supports the next phase of development of SBO-154 which has completed ...

Read more

31 Mar 2025 13:58

News

Volumes jump at Sun Pharma Advanced Research Company Ltd counter

Kalpataru Projects International Ltd, Inox Wind Ltd, Data Patterns (India) Ltd, Triveni Tu...

Read more

07 Mar 2025 14:30

News

Sun Pharma Advanced Research Company to hold board meeting

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

01 Feb 2025 10:56

News

Sun Pharma Advanced Research Company to acquire 55% stake in Tiller Therapeutics

Sun Pharma Advanced Research Company announced the signing of a binding Letter of Intent (...

Read more

17 Dec 2024 09:34

SWOT Analysis Of Alkem Laboratories Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sun Pharma Advanced Research Company Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Alkem Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharma Advanced Research Company Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alkem Laboratories Ltd and Sun Pharma Advanced Research Company Ltd

Which company has a larger market capitalization, Alkem Laboratories Ltd or Sun Pharma Advanced Research Company Ltd?

Market cap of Alkem Laboratories Ltd is 63,192 Cr while Market cap of Sun Pharma Advanced Research Company Ltd is 5,302 Cr

What are the key factors driving the stock performance of Alkem Laboratories Ltd and Sun Pharma Advanced Research Company Ltd?

The stock performance of Alkem Laboratories Ltd and Sun Pharma Advanced Research Company Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alkem Laboratories Ltd and Sun Pharma Advanced Research Company Ltd?

As of May 24, 2025, the Alkem Laboratories Ltd stock price is INR ₹5285.2. On the other hand, Sun Pharma Advanced Research Company Ltd stock price is INR ₹163.4.

How do dividend payouts of Alkem Laboratories Ltd and Sun Pharma Advanced Research Company Ltd compare?

To compare the dividend payouts of Alkem Laboratories Ltd and Sun Pharma Advanced Research Company Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions